Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
about
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilitiesHigh Times for Painful Blues: The Endocannabinoid System in Pain-Depression ComorbidityCannabinoid and opioid interactions: implications for opiate dependence and withdrawalThe endocannabinoid system as a potential therapeutic target for pain modulationThe Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model.Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects.Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors.In vivo characterization of MMP-2200, a mixed δ/μ opioid agonist, in mice.Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non-cannabinoid receptor-mediated mechanisms.Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal grayCombined Treatment with Morphine and Δ9-Tetrahydrocannabinol in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal.The analgesic potential of cannabinoids.Emerging strategies for exploiting cannabinoid receptor agonists as medicines.Repeated cannabinoid injections into the rat periaqueductal gray enhance subsequent morphine antinociception.Prolonged exposure to WIN55,212-2 causes downregulation of the CB1 receptor and the development of tolerance to its anticonvulsant effects in the hippocampal neuronal culture model of acquired epilepsy.Interaction of the cannabinoid and opioid systems in the modulation of nociception.Interactions between Δ(9)-tetrahydrocannabinol and heroin: self-administration in rhesus monkeys.Persistent peripheral inflammation attenuates morphine-induced periaqueductal gray glial cell activation and analgesic tolerance in the male rat.Is there any clinically relevant cannabinoid-induced analgesia?Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.The dynamic interaction between pain and opioid misuse.Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis.Analysis of the anti-allodynic effects of combination of a synthetic cannabinoid and a selective noradrenaline re-uptake inhibitor in nerve injury-induced neuropathic mice.The prescription of medical cannabis by a transitional pain service to wean a patient with complex pain from opioid use following liver transplantation: a case report.Delay of morphine tolerance by palmitoylethanolamide.Opioid and cannabinoid synergy in a mouse neuropathic pain model.Role of the guanine nucleotide binding protein, Gαo, in the development of morphine tolerance and dependence.Antinociceptive effects of mixtures of mu opioid receptor agonists and cannabinoid receptor agonists in rats: Impact of drug and fixed-dose ratio.Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability.Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort.Emerging Evidence for Cannabis' Role in Opioid Use Disorder
P2860
Q24623282-6D6ADFFB-0084-47C8-B4F3-59F2BD95C7CFQ26784030-A54C1C8E-81A9-4DB5-B472-BB8AB7541590Q27000762-60B3ABEE-8083-46DF-9F01-B3F1AF89F164Q28247621-716DCC46-7A7A-4A28-A942-E99FA4F7DCC8Q30733453-9B46E9FF-E0F7-4662-BC4D-75114FA71C1BQ33618200-BD83C908-AA26-4477-AED0-CD97CDE8E359Q33715462-C598A2F8-AA1A-41BE-8ECE-6FD577E3276AQ34702263-250A4B08-8655-4C02-8AE9-BB89B742B279Q34801735-1F08711A-80E8-48E2-BCD6-30385FFFBD93Q36007619-9C36A7FD-8BDA-4113-A5E9-F9E6C230C0C7Q36852565-ED46E91F-3487-4143-BE8B-7CA2F6E7F7B2Q37057325-834760ED-5C39-41F0-AA6E-CF0DDE402AABQ37230665-3C84DD3B-2C91-4555-9217-2CD8C77127E2Q37345505-B24E4814-C903-4737-B53A-8513AA0B5044Q37375454-FA6D68A3-E3A2-412F-95F8-05651333192AQ37444813-84C2B76F-47AA-413E-A220-BC947CA04AB2Q37564992-8BC92403-605B-4DD9-9CC4-6F8343ADFD9DQ37710121-5EA7B321-6DE3-4F44-92BC-428653C18FECQ38003023-B5C02A10-494C-44AF-BC20-EB62669C5900Q38503842-A72B0480-85CB-4500-A686-E70E9CDD3C66Q38600704-17FDA5A7-5A0F-4A5D-92C1-621E0FA517E6Q38731968-86AA09F4-4429-4313-8D81-48538023E635Q39192669-FB1F6494-BD68-4875-A9FE-F9AF781D55DCQ40701683-F3C0ED58-F39C-40DF-B03E-465414860978Q41178764-EC4C9F79-7744-41CD-B635-ECC3529911D0Q41908176-AAF42FE3-8BB3-40AA-90D7-FCD1AE9016A6Q42406036-5897BFAB-B6F6-4115-8081-245722C54B34Q47711187-3B9DD7EA-6698-406E-A8CC-DD968F59DCC6Q47777896-169EFC12-D362-4555-BA02-B632E0E2AFC4Q49788859-D0E22704-7B66-43CB-AB94-4772ED60AFBDQ55333056-DA3D9C56-5AC3-4C23-A516-DB173D208C4EQ58775143-05D00277-B751-4A12-AD15-26A5A389BEC8
P2860
Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Low dose combination of morphi ...... desensitization of receptors.
@ast
Low dose combination of morphi ...... desensitization of receptors.
@en
type
label
Low dose combination of morphi ...... desensitization of receptors.
@ast
Low dose combination of morphi ...... desensitization of receptors.
@en
prefLabel
Low dose combination of morphi ...... desensitization of receptors.
@ast
Low dose combination of morphi ...... desensitization of receptors.
@en
P2093
P2860
P1476
Low dose combination of morphi ...... desensitization of receptors.
@en
P2093
Dana E Selley
Laura J Sim-Selley
Paul A Smith
Sandra P Welch
P2860
P304
P356
10.1016/J.EJPHAR.2007.06.001
P407
P577
2007-06-12T00:00:00Z